Pediatric Otolaryngology in COVID-19.

Scott Rickert, Reza Rahbar

Abstract readReview

In one paragraph

Review in Otolaryngologic clinics of North America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Outpatient characteristics in a pediatric otolaryngology department during COVID-19 pandemic: A retrospective study.Science progress
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Scott RickertDivision of Pediatric Otolaryngology, Department of Otolaryngology, Pediatrics, and Plastic Surgery, Hassenfeld Children's Hospital at NYU Langone, NYU Langone Health, 240 East 38th Street, New York, NY 10016, USA. Electronic address: scott.rickert@nyulangone.org.

Reza RahbarCenter for Airway Disorders, Neck and Skull Base Surgery Program, Harvard Medical School; Department of Otolaryngology & Communication Enhancement, 333 Longwood Avenue, Boston, MA 02115, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While the majority of the initial attention to symptomatic COVID-19 focused on adult patients as well as adult critical care and first responders, the pandemic drastically altered care throughout the entire health care industry. COVID-19 has had a profound effect on the treatment and care of pediatric patients within pediatric otolaryngology. The objective of this article is to highlight the unique ramifications of COVID-19 in general and its effect within pediatric otolaryngology, with a focus on the immediate and potential long-term shifts in practice. This article addresses several aspects of care within pediatric otolaryngology including safety, diagnosis, and treatment of COVID-19 detailing the unique effects of the pandemic on the pediatric otolaryngology specialty and opportunities.

Indexed as

COVID-19OtolaryngologyAdultChildHumansPandemicsSARS-CoV-2COVID-19Nose and throatPediatric earPediatric otolaryngology

Identifiers

PMID36224059

DOI10.1016/j.otc.2022.07.020

PMCPMC9359934

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.